Dimension Capital’s $800M third fund shows the intersection of science and compute is booming
The four-year-old firm’s latest fund is 60% larger than its second vehicle announced 18 months ago.
biotech
What happens in Vega$: steroids, swimmers, and a billion-dollar hustle
The Enhanced Games — a singular sporting competition where a majority of the athletes were on performance enhancing drugs — may herald a new business model that the tech industry is ready to embrace.
I went to the so-called ‘steroid Olympics,’ to understand why Silicon Valley is obsessed with peptides
The Enhanced Games — a singular sporting competition where a majority of the athletes were on performance enhancing drugs — may herald a new business model that the tech industry is ready to embrace.
Imperagen raises £5 million to use quantum physics, AI on enzyme engineering
Biotech company Imperagen announced on Thursday a £5 million ($6.7 million) seed round led by PXN Ventures, with participation from IQ Capital and Northern Gritstone.
From OpenAI’s offices to a deal with Eli Lilly — how Chai Discovery became one of the flashiest names in AI drug development
The startup has partnered with Eli Lilly and enjoys the backing of some of Silicon Valley’s most influential VCs.
Eclipse Energy’s microbes can turn idle oil wells into hydrogen factories
The biotech startup is betting that owners of abandoned oil wells will use the tech to squeeze energy out of their wells.
Miraqules will showcase its blood clotting technology at TechCrunch Disrupt 2025
India-based Miraqules developed a nanotechnology that mimics blood clotting proteins to quickly stop heavy bleeding.
Catalio Capital closes over $400M Fund IV
Catalio Capital Management announced the closing of its more than $400 million Fund IV. The fund will continue the firm’s thesis of backing healthcare and biotechnology companies.